EUVIMEDEUVIMED entdecken
Open Access

Pediatric high-grade gliomas, H3-wildtype, IDH-wildtype: Refining diagnostic criteria and exploring clinical associations

Supriya Bhardwaj, Jyotsna Singh, Swati Singh, Charli Roy, Hemlata Jangir iD, Srinidhi Vasant, Shweta Kedia, Ajay Garg, Ashish Suri, Mehar Chand Sharma iD, Chitra Sarkar, Vaishali Suri iD

Neuro-Oncology Practice · 01.02.2026 · 13 (1) · 97-104

DOI: 10.1093/nop/npaf079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology Practice, online erschienen am 03.08.2025. Verfasst von Supriya Bhardwaj und 11 weiteren Autor:innen. Beteiligte Einrichtung: Neuropathology Laboratory, All India Institute of Medical Sciences, New Delhi, India. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diffuse pediatric-type high-grade gliomas (pHGGs), H3-wildtype (H3 WT), and IDH-wildtype (IDH WT), represent a newly recognized, highly malignant brain tumor entity with unique molecular and epigenetic profiles. Despite their recent inclusion in the WHO 2021 classification, their histological and molecular diversity presents significant diagnostic and therapeutic challenges.

Methods

This study analyzed 12 cases of pHGGs, H3 WT and IDH WT, identified through whole-genome methylation profiling. Clinical, radiological, and histopathological evaluations were complemented by immunohistochemical profiling, employing an extended spectrum of antibodies, and molecular studies. Methylation profiling enabled precise tumor classification and correlation with known subtypes such as RTK-1, RTK-2, and MYCN.

Results

Among the 12 cases, 7 were classified under the RTK-1 subtype, 3 under RTK2 subtype, and a case each under MYCN, pHGGs, H3 WT, and IDH WT subtype B. Notably, 5/12 cases demonstrated a loss of H3K27me3 expression, contradicting the WHO 2021 recommendation for its retention as a diagnostic criterion. Furthermore, 6/7 RTK-1 subtype cases were linked to either mismatch-repair (MMR) deficiency or radiation-induced gliomas, highlighting an enrichment of these clinical scenarios within this subgroup. MGMT promoter methylation was observed in only 4/12 of these cases, consistent with its low prevalence in this tumor category.

Conclusions

This study provides a comprehensive characterization of pHGGs, H3 WT, IDH WT, and emphasizes the clinical and molecular complexity of this rare tumor entity. The findings challenge current WHO diagnostic criteria regarding H3K27me3 retention and demonstrate the critical role of molecular diagnostics, particularly methylation profiling, in refining classification and guiding clinical management. These results advocate for re-evaluation of existing diagnostic frameworks to better accommodate the observed variability and associations in this challenging tumor subtype.

Schlagwörter

Stichwörter der Autor:innen

H3K27me3 expressiondiffuse pediatric high-grade glioma H3-wildtype IDH-wildtypemethylation profilingmismatch-repair deficiencyradiation-induced gliomas

Autor:innen und Institutionen

  • Neuropathology Laboratory, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Neuroimaging and Interventional Neuroradiology, All India Institute of Medical Science, New Delhi, India.
  • Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.

ORCID-Profile: Hemlata Jangir, Mehar Chand Sharma, Vaishali Suri

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Bhardwaj, S., Singh, J., Singh, S., Roy, C., Jangir, H., Vasant, S., Kedia, S., Garg, A., Suri, A., Sharma, M. C., Sarkar, C., & Suri, V. (2026). Pediatric high-grade gliomas, H3-wildtype, IDH-wildtype: Refining diagnostic criteria and exploring clinical associations. Neuro-Oncology Practice, 13(1), 97-104. https://doi.org/10.1093/nop/npaf079

Vancouver

Bhardwaj S, Singh J, Singh S, Roy C, Jangir H, Vasant S, et al. Pediatric high-grade gliomas, H3-wildtype, IDH-wildtype: Refining diagnostic criteria and exploring clinical associations. Neuro-Oncology Practice. 2026;13(1):97-104. doi:10.1093/nop/npaf079

BibTeX
@article{Bhardwaj2026,
  author = {Bhardwaj, Supriya and Singh, Jyotsna and Singh, Swati and Roy, Charli and Jangir, Hemlata and Vasant, Srinidhi and Kedia, Shweta and Garg, Ajay and Suri, Ashish and Sharma, Mehar Chand and Sarkar, Chitra and Suri, Vaishali},
  title = {Pediatric high-grade gliomas, H3-wildtype, IDH-wildtype: Refining diagnostic criteria and exploring clinical associations},
  journal = {Neuro-Oncology Practice},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {97--104},
  doi = {10.1093/nop/npaf079}
}
Kostenlos starten →